NCT02486718 2026-02-05
Study to Assess Safety and Efficacy of Atezolizumab (MPDL3280A) Compared to Best Supportive Care Following Chemotherapy in Patients With Lung Cancer [IMpower010]
Hoffmann-La Roche
Phase 3 Active not recruiting
Hoffmann-La Roche
Hoffmann-La Roche
AstraZeneca